A 50-year-old man presented with exertional angina and a positive treadmill test. Coronary angiography demonstrated a significant lesion in the mid-right coronary artery, and he proceeded to percutaneous coronary intervention. Because implantation of a bioresorbable vascular scaffold (BVS) (Abbott Vascular, Santa Clara, California) was considered, intracoronary imaging was performed using both intravascular ultrasound (IVUS) (Eagle-Eye Platinum, Volcano Corporation, San Diego, California) and optical coherence tomography (OCT) (Dragonfly C7, St. Jude Medical, St. Paul, Minnesota) to accurately assess the proximal and distal reference diameter. The lesion was adequately pre-dilated with a 3.0 Â 15-mm Emerge balloon (Boston Scientific, Natick, Massachusetts) with subsequent implantation of a 3.0 Â 18-mm BVS at 16 atm (Fig. 1, left panel) . 
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